Cite
Carter CA, Schmitz B, Peterson PG, et al. Immune Reactivity and Pseudoprogression or Tumor Flare in a Serially Biopsied Neuroendocrine Patient Treated with the Epigenetic Agent RRx-001. Case Rep Oncol. 2016;9(1):164-70doi: 10.1159/000444633.
Carter, C. A., Schmitz, B., Peterson, P. G., Quinn, M., Degesys, A., Jenkins, J., Oronsky, B., Scicinski, J., Caroen, S., Reid, T. R., Cabrales, P., & Brzezniak, C. (2016). Immune Reactivity and Pseudoprogression or Tumor Flare in a Serially Biopsied Neuroendocrine Patient Treated with the Epigenetic Agent RRx-001. Case reports in oncology, 9(1), 164-70. https://doi.org/10.1159/000444633
Carter, Corey A, et al. "Immune Reactivity and Pseudoprogression or Tumor Flare in a Serially Biopsied Neuroendocrine Patient Treated with the Epigenetic Agent RRx-001." Case reports in oncology vol. 9,1 (2016): 164-70. doi: https://doi.org/10.1159/000444633
Carter CA, Schmitz B, Peterson PG, Quinn M, Degesys A, Jenkins J, Oronsky B, Scicinski J, Caroen S, Reid TR, Cabrales P, Brzezniak C. Immune Reactivity and Pseudoprogression or Tumor Flare in a Serially Biopsied Neuroendocrine Patient Treated with the Epigenetic Agent RRx-001. Case Rep Oncol. 2016 Mar 10;9(1):164-70. doi: 10.1159/000444633. eCollection 2016. PMID: 27065848; PMCID: PMC4821155.
Copy
Download .nbib